PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: PEPTIDES+ (BRAIN SUPPORT)
DRUG NAME: PINEALON

• FDA Safety Data Sheet not available (experimental peptide).

• Kraskovskaya N. Short Peptides Protect Fibroblast-Derived Induced Neurons from Age-Related Changes. Int J Mol Sci. 2024 [PubMed Link]

• Khavinson V. Short Peptides and Telomere Length Regulator Hormone Irisin. Bull Exp Biol Med. 2016 [PubMed Link]

• Khavinson V. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Res. 2011 [PubMed Link]

• Kozina LS. Investigation of antihypoxic properties of short peptides. Adv Gerontol. 2008 [PubMed Link]

• Khavinson V. Short peptides stimulate serotonin expression in cells of brain cortex. Bull Exp Biol Med. 2014 [PubMed Link]

• Meshchaninov VN. Effect of synthetic peptides on aging of patients with chronic polymorbidity and organic brain sydrome of the central nervous system in remission. Adv Gerontol. 2015 [PubMed Link]

• Fedoreyeva L. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Mosc). 2011 [PubMed Link]

• Voicekhovskaya MA. Effect of bioregulatory tripeptides on the culture of skin cells from young and old rats. Bull Exp Biol Med. 2012 [PubMed Link]